1. Home
  2. CGC vs RCKT Comparison

CGC vs RCKT Comparison

Compare CGC & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

HOLD

Current Price

$0.94

Market Cap

401.0M

Sector

Health Care

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.43

Market Cap

401.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CGC
RCKT
Founded
N/A
1999
Country
Canada
United States
Employees
N/A
202
Industry
Pharmaceuticals and Biotechnology
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.0M
401.6M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
CGC
RCKT
Price
$0.94
$3.43
Analyst Decision
Hold
Buy
Analyst Count
1
14
Target Price
N/A
$29.73
AVG Volume (30 Days)
4.2M
3.1M
Earning Date
05-29-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
84.17
N/A
EPS
N/A
N/A
Revenue
$12,759,000.00
N/A
Revenue This Year
$8.27
N/A
Revenue Next Year
$15.68
$64.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.84
$2.53
52 Week High
$2.38
$5.45

Technical Indicators

Market Signals
Indicator
CGC
RCKT
Relative Strength Index (RSI) 40.31 46.97
Support Level $0.84 $3.36
Resistance Level $1.08 $3.56
Average True Range (ATR) 0.04 0.24
MACD 0.00 -0.05
Stochastic Oscillator 8.80 19.91

Price Performance

Historical Comparison
CGC
RCKT

About CGC Canopy Growth Corporation

Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: